Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases.
暂无分享，去创建一个
Jun Yu Li | M. Favata | P. Scherle | M. Covington | Yan Zhang | S. Diamond | W. Yao | R. Newton | C. Xue | Xin He | Ashish Juvekar | M. Scuron | N. Shin | R. Collins | K. Burke | Michael T. Peel | Taisheng Huang | Paul A. Smith | Karen Gallagher | Sarala Sarah | Julian Oliver | Brittany L. Fay